NCT02658981 2023-10-06Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Completed63 enrolled